Tags » GlaxoSmithKline

J&J, Glaxo settle U.S. lawsuit over allergy ads

(REUTERS) — GlaxoSmithKline has agreed to settle a lawsuit by Johnson & Johnson accusing it of using false advertising at the start of the U.S. allergy season to grab market share. 190 more words


How Big Pharma GlaxoSmithKline is managing its R&D Collaborations - Xconomy

Being close to scientific innovators is key

Cambridge and San Diego are two main centers for innovation in life sciences, according to GlaxoSmithKline. Actually the big pharma established a “first-of-its-kind collaboration” with San Diego’s Avalon Ventures in 2013; lastly it has opened a small office in San Diego to manage its R&D partnerships and to prospect for more deals on the West Coast. 39 more words

Trend Box

Firategrast, T-0047


Firategrast, 402567-16-2;

Firategrast, MS, Alpha4beta1 integrin


Mitsubishi Tanabe Pharma INNOVATOR

Tanabe Seiyaku Co

Glaxo Group Limited, Mitsubishi Tanabe Pharma Corporation… 2,970 more words

Phase2 Drugs

All British babies to get new meningitis B vaccine in landmark deal after months of negotiation over price finally resolved

Over price finally resolved!!!!! This statment alone should be ringing alarm bells. If not you’re too far gone.

All babies in the UK will have a potentially life-saving vaccine against meningitis B under a landmark deal, the Health Secretary has announced. 58 more words


Women in Science

Today, I participated in the North Carolina GlaxoSmithKline Foundation’s Women in Science spring conference, which was held at the Museum.  The GSK Foundation funds and mentors female students enrolled in science programmes in North Carolina.  223 more words


Pharma to the Public: "Trust Our Vaccines! Our Cover-ups Are Working! Our Research Is Fake!"

The pharmaceutical industry has a “dead earnest” intent, right now, to push through vaccine mandates.  And they have a lot working for them – their control of media, of medical journals, of research and of Congress. 1,906 more words


Why International Double Jeopardy Is a Bad Idea

In a recent post, I argued that U.S. authorities investigating British pharma giant GlaxoSmithKline (“GSK”) should consider criminally prosecuting GSK but partially offsetting any attendant penalty in light of the $490 million fine already imposed by China. 996 more words